Intravenous (IV) Solution Manufacturing
Given the latest surge in saline demand and the overall steady growth of demand from group purchasing organizations (GPOs) and hospitals, IBISWorld expects industry revenue to increase at an annualized rate of 4.1% to $1.7 billion over the five years to 2018, with revenue expected to increase 6.6% in 2018. Market expansion over the next five years is expected to be driven by several factors, including increasing prevalence of chronic disease, the increasing severity of seasonal flu outbreaks and increasing natality rates. Moreover, as the US population continues to expand, demand for industry products is slated to increase.
Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.